Literature DB >> 31801814

Extremely Preterm Infants Have Significant Alterations in Their Conventional T Cell Compartment during the First Weeks of Life.

Khaleda Rahman Qazi1, Georg Bach Jensen2,3, Marieke van der Heiden4, Sophia Björkander4, Ulrika Holmlund4, Yeneneh Haileselassie4, Efthymia Kokkinou4, Giovanna Marchini5, Maria C Jenmalm2, Thomas Abrahamsson2,3, Eva Sverremark-Ekström4.   

Abstract

Extremely preterm neonates are particularly susceptible to infections, likely because of severely impaired immune function. However, little is known on the composition of the T cell compartment in early life in this vulnerable population. We conducted a comprehensive phenotypic flow cytometry-based longitudinal analysis of the peripheral conventional T cell compartment of human extremely low gestational age neonates (ELGAN) with extremely low birth weight (ELBW; <1000 g) participating in a randomized placebo-controlled study of probiotic supplementation. PBMCs from ELGAN/ELBW neonates were collected at day 14, day 28, and postmenstrual week 36. Comparisons were made with full-term 14-d-old neonates. Total CD4+ and CD8+ T cell frequencies were markedly lower in the preterm neonates. The reduction was more pronounced among the CD8+ population, resulting in an increased CD4/CD8 ratio. The preterm infants were also more Th2 skewed than the full-term infants. Although the frequency of regulatory T cells seemed normal in the ELGAN/ELBW preterm neonates, their expression of the homing receptors α4β7, CCR4, and CCR9 was altered. Notably, ELGAN/ELBW infants developing necrotizing enterocolitis before day 14 had higher expression of CCR9 in CD4+T cells at day 14. Chorioamnionitis clearly associated with reduced T regulatory cell frequencies and functional characteristics within the preterm group. Finally, probiotic supplementation with Lactobacillus reuteri did not impose any phenotypic changes of the conventional T cell compartment. In conclusion, notable immaturities of the T cell compartment in ELGAN/ELBW neonates may at least partially explain their increased susceptibility to severe immune-mediated morbidities.
Copyright © 2019 by The American Association of Immunologists, Inc.

Entities:  

Year:  2019        PMID: 31801814      PMCID: PMC6926392          DOI: 10.4049/jimmunol.1900941

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  53 in total

1.  Maturation of CD4+ regulatory T lymphocytes and of cytokine secretions in infants born prematurely.

Authors:  V Dirix; F Vermeulen; F Mascart
Journal:  J Clin Immunol       Date:  2013-06-21       Impact factor: 8.317

2.  Effect of chorioamnionitis on regulatory T cells in moderate/late preterm neonates.

Authors:  Cesar M Rueda; Casey B Wells; Tate Gisslen; Alan H Jobe; Suhas G Kallapur; Claire A Chougnet
Journal:  Hum Immunol       Date:  2014-11-08       Impact factor: 2.850

3.  Fetal and adult hematopoietic stem cells give rise to distinct T cell lineages in humans.

Authors:  Jeff E Mold; Shivkumar Venkatasubrahmanyam; Trevor D Burt; Jakob Michaëlsson; Jose M Rivera; Sofiya A Galkina; Kenneth Weinberg; Cheryl A Stoddart; Joseph M McCune
Journal:  Science       Date:  2010-12-17       Impact factor: 47.728

Review 4.  Diagnosis and management of clinical chorioamnionitis.

Authors:  Alan T N Tita; William W Andrews
Journal:  Clin Perinatol       Date:  2010-06       Impact factor: 3.430

5.  CD4+ T cells from human neonates and infants are poised spontaneously to run a nonclassical IL-4 program.

Authors:  Katrin Hebel; Soenke Weinert; Benno Kuropka; Julienne Knolle; Bernhard Kosak; Gerhard Jorch; Christoph Arens; Eberhard Krause; Ruediger C Braun-Dullaeus; Monika C Brunner-Weinzierl
Journal:  J Immunol       Date:  2014-04-28       Impact factor: 5.422

6.  Developmentally determined reduction in CD31 during gestation is associated with CD8+ T cell effector differentiation in preterm infants.

Authors:  Kristin M Scheible; Jason Emo; Hongmei Yang; Jeanne Holden-Wiltse; Andrew Straw; Heidie Huyck; Sara Misra; David J Topham; Rita M Ryan; Anne Marie Reynolds; Thomas J Mariani; Gloria S Pryhuber
Journal:  Clin Immunol       Date:  2015-07-29       Impact factor: 3.969

7.  Lactobacillus Reuteri for the prevention of necrotising enterocolitis in very low birthweight infants: a randomised controlled trial.

Authors:  Mehmet Yekta Oncel; Fatma Nur Sari; Sema Arayici; Nilufer Guzoglu; Omer Erdeve; Nurdan Uras; Serife Suna Oguz; Ugur Dilmen
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2013-12-05       Impact factor: 5.747

8.  Pre- and postnatal administration of Lactobacillus reuteri decreases TLR2 responses in infants.

Authors:  Anna Forsberg; Thomas R Abrahamsson; Bengt Björkstén; Maria C Jenmalm
Journal:  Clin Transl Allergy       Date:  2014-06-25       Impact factor: 5.871

Review 9.  Unbalanced Neonatal CD4(+) T-Cell Immunity.

Authors:  Isabelle Debock; Véronique Flamand
Journal:  Front Immunol       Date:  2014-08-27       Impact factor: 7.561

10.  Reduced generation of lung tissue-resident memory T cells during infancy.

Authors:  Kyra D Zens; Jun Kui Chen; Rebecca S Guyer; Felix L Wu; Filip Cvetkovski; Michelle Miron; Donna L Farber
Journal:  J Exp Med       Date:  2017-08-30       Impact factor: 14.307

View more
  10 in total

1.  Premature Infants Have Normal Maturation of the T Cell Receptor Repertoire at Term.

Authors:  Sarah U Morton; Maureen Schnur; Rylee Kerper; Vanessa Young; Amy E O'Connell
Journal:  Front Immunol       Date:  2022-05-30       Impact factor: 8.786

Review 2.  Bench to bedside - new insights into the pathogenesis of necrotizing enterocolitis.

Authors:  David J Hackam; Chhinder P Sodhi
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-03-28       Impact factor: 73.082

3.  Cesarean delivery and risk of hospitalization for autoimmune disorders before 14 years of age.

Authors:  Safiya Soullane; Mélanie Henderson; Harb Kang; Thuy Mai Luu; Ga Eun Lee; Nathalie Auger
Journal:  Eur J Pediatr       Date:  2021-05-26       Impact factor: 3.183

4.  Intestinal Regulatory T Cells.

Authors:  Vanessa R Figliuolo da Paz; Deepa R Jamwal; Pawel R Kiela
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

5.  Indole-3-Carbinol-Dependent Aryl Hydrocarbon Receptor Signaling Attenuates the Inflammatory Response in Experimental Necrotizing Enterocolitis.

Authors:  Lila S Nolan; Belgacem Mihi; Pranjal Agrawal; Qingqing Gong; Jamie M Rimer; Shay S Bidani; Sarah E Gale; Martin Goree; Elise Hu; Wyatt E Lanik; Elizabeth Huang; Jennifer K Bando; Victoria Liu; Angela N Lewis; Aiza Bustos; Zerina Hodzic; Marie L Laury; Misty Good
Journal:  Immunohorizons       Date:  2021-04-27

Review 6.  Dysregulated Mucosal Immunity and Associated Pathogeneses in Preterm Neonates.

Authors:  Maame Efua S Sampah; David J Hackam
Journal:  Front Immunol       Date:  2020-05-15       Impact factor: 7.561

Review 7.  Understanding Early-Life Adaptive Immunity to Guide Interventions for Pediatric Health.

Authors:  Eleanor C Semmes; Jui-Lin Chen; Ria Goswami; Trevor D Burt; Sallie R Permar; Genevieve G Fouda
Journal:  Front Immunol       Date:  2021-01-21       Impact factor: 8.786

8.  Immune Profiling of Cord Blood From Preterm and Term Infants Reveals Distinct Differences in Pro-Inflammatory Responses.

Authors:  Jeremy Anderson; Cao Minh Thang; Le Quang Thanh; Vo Thi Trang Dai; Van Thanh Phan; Bui Thi Hong Nhu; Do Ngoc Xuan Trang; Phan Thi Phuong Trinh; Thuong Vu Nguyen; Nguyen Trong Toan; Christopher M Harpur; Kim Mulholland; Daniel G Pellicci; Lien Anh Ha Do; Paul V Licciardi
Journal:  Front Immunol       Date:  2021-11-01       Impact factor: 7.561

9.  Composition of early life leukocyte populations in preterm infants with and without late-onset sepsis.

Authors:  Julie Hibbert; Tobias Strunk; Elizabeth Nathan; Amy Prosser; Dorota Doherty; Karen Simmer; Peter Richmond; David Burgner; Andrew Currie
Journal:  PLoS One       Date:  2022-03-02       Impact factor: 3.240

10.  Extreme prematurity and sepsis strongly influence frequencies and functional characteristics of circulating γδ T and natural killer cells.

Authors:  Khaleda Rahman Qazi; Georg B Jensen; Marieke van der Heiden; Sophia Björkander; Giovanna Marchini; Maria C Jenmalm; Thomas Abrahamsson; Eva Sverremark-Ekström
Journal:  Clin Transl Immunology       Date:  2021-06-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.